Genmab — Oktober 2019
-
Servicemeddelelse: Vi arbejder i maskinrummet i nat. Der kan derfor komme perioder, hvor siden er nede. I morgen tidlig er vi klar igen.
-
Velkommen til ny redaktør på Proinvestor: https://www.proinvestor.com/debat/78394
-
God morgen
-
Og velkommen til en række omrokeringer og ændringer på forsiden.
-
Sommertiden får vi rettet i løbet af dagen.
-
PURPOSE
Observation is the current standard of care for smoldering multiple myeloma. We hypothesized that early intervention with lenalidomide could delay progression to symptomatic multiple myeloma. https://ascopubs.org/doi/full/10.1200/JCO.19.01740
-
Servicemeddelelse: Vi har nu etableret
"Chat nyheder". Her vil Marthine og jeg løbende fra tidlig morgen til sen aften poste markedsnyheder, kommentarer og videoer fra vort skandinaviske og globale netværk. https://www.proinvestor.com/chathistory/58/chat nyheder -
God morgen
-
God morgen.
-
Morgennyheder på PI: https://www.proinvestor.com/chathistory/58/chat nyheder
-
God morgen
-
a bit more on smoldering "CONCLUSION Early intervention with lenalidomide in smoldering multiple myeloma significantly delays progression to symptomatic multiple myeloma and the development of end-organ damage." https://ascopubs.org/doi/pdf/10.1200/JCO.19.01740
-
and comments from Rajkumar on this trial
https://twitter.com/VincentRK/status/1188122898499821568 -
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind